Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
IUBMB Life|November 17, 2004
Mitochondrial dysfunction by synthetic ligands of peroxisome proliferator activated receptors (PPARs)Roberto Scatena, Giuseppe E Martorana, Patrizia Bottoni, et al.
Expert Opinion on Investigational Drugs|July 19, 2005
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potentialRoberto Scatena, Patrizia Bottoni, Giuseppe E Martorana, et al.
Biochimica Et Biophysica Acta|April 2, 2009
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell linePatrizia Bottoni, Bruno Giardina, Alberto Vitali, et al.
Expert Opinion on Investigational Drugs|September 24, 2008
Glycolytic enzyme inhibitors in cancer treatmentRoberto Scatena, Patrizia Bottoni, Alessandro Pontoglio, et al.
Advances in Experimental Medicine and Biology|March 9, 2012
Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancerPatrizia Bottoni, Bruno Giardina, Alessandro Pontoglio, et al.
American Journal of Physiology. Cell Physiology|May 4, 2007
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topicRoberto Scatena, Patrizia Bottoni, Giorgia Botta, et al.
Cells|April 12, 2022
Mitochondrial Respiratory Complexes as Targets of Drugs: The PPAR Agonist ExamplePatrizia Bottoni, Alessandro Pontoglio, Salvatore Scarà, et al.
Advances in Clinical Chemistry|May 29, 2026
Mitochondrial myopathy biomarkersMarco Refrigeri, Alessandra Tola, Rosangela Mogavero, et al.
Expert Opinion on Investigational Drugs|December 13, 2006
An update on pharmacological approaches to neurodegenerative diseasesRoberto Scatena, Giuseppe E Martorana, Patrizia Bottoni, et al.
Pageof 5